Rheumatoid factor as predictor of response to treatment with anti-TNF alpha drugs in patients with rheumatoid arthritis: Results of a cohort study

We determined whether rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACPA) can predict remission or severe disability in rheumatoid arthritis (RA) patients treated with anti-tumor necrosis factor (TNF) alpha drugs. We performed a cohort study based on the clinical data from a...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos-Moreno, Pedro, Sánchez, Guillermo, Castro, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380754/
https://www.ncbi.nlm.nih.gov/pubmed/30702571
http://dx.doi.org/10.1097/MD.0000000000014181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380754/
https://www.ncbi.nlm.nih.gov/pubmed/30702571
http://dx.doi.org/10.1097/MD.0000000000014181

Ejemplares similares